DaVita shareholders ask federal judge to approve $50M from executives to settle insurance scheme action -
DaVita shareholders brought the derivative action forward over a scheme by the company to steer dialysis patients toward private insurers and away from government backed plans. Besides the cash payout from DaVita’s directors and officers insurance, the deal would include changes to the organization’s structure. These reforms are meant to increase the independence of board members and if accepted, would also separate the roles of board chair and CEO and permit incentive clawbacks in the event of significant misconduct.
Please see full Newsletter below for more information.